Fundraising Fox
/Companies
Sign in

Kira Pharmaceuticals

Cambridge, US · 5 known investors

Find your way into Kira Pharmaceuticals

Each arrow is one introduction. Sign up to fill in the first one.

446 people can intro you to Wenru

Ask Christina Weng to introduce you to Wenru Song

You →Christina · together at Kira Pharmaceuticals →Wenru

Sign up to find every way you can get introduced to Kira Pharmaceuticals

  • Your email: who you already know at Kira Pharmaceuticals, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kira Pharmaceuticals team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Kira Pharmaceuticals is a biotech company developing therapies targeting complement biology to treat complement-mediated diseases. Its work combines drug development and protein engineering, supported by academic collaborators and a scientific advisory board in complement biology and immunology.

BiotechHealthtech

Founders & leadership

WSWenru Song
Wenru SongCo-Founder, President and Head of R&DWenru Song is a board-certified medical oncologist with background in academic clinical and translational research and pharmaceutical drug development. She founded Kira Pharmaceuticals, a biotech company developing complement-targeted therapies for complement-mediated diseases.

Investors · 5

Quan Capitallisted by Quan CapitalShanghai
Vivo Capitallisted by Vivo CapitalPalo Alto · $10M – $50M

How we know: Vivo Capital's portfolio page · Not right? Tell us

Ikarian CapitalreportedDallas

How we know: blockonomi.com · Not right? Tell us

Also in the syndicate · 1

Affinity Asset Advisorslead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapiesprnewswire.com · Jan 2021

Frequently asked questions

What does Kira Pharmaceuticals do?
Kira Pharmaceuticals is a biotech company developing therapies targeting complement biology to treat complement-mediated diseases. Its work combines drug development and protein engineering, supported by academic collaborators and a scientific advisory board in complement biology and immunology.
Who founded Kira Pharmaceuticals?
Kira Pharmaceuticals was founded by Wenru Song.
Who are Kira Pharmaceuticals's investors?
Kira Pharmaceuticals's investors include Foresite Capital, Quan Capital, Vivo Capital, Ikarian Capital.
Where is Kira Pharmaceuticals headquartered?
Kira Pharmaceuticals is headquartered in Cambridge, US.